loader

Diagnos

TSXV:ADK
DGNOF
1 min read

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy.

DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025

DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit

Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA

DIAGNOS Announces Voting Results of Meeting of Shareholders

DIAGNOS Announces Closing of Private Placement

DIAGNOS Announces Private Placement

DIAGNOS to Extend Stock Warrants Exercise Period

DIAGNOS Announces Extension of Stock Warrants Exercise Period

DIAGNOS Announces Corporate Debt Reorganization

DIAGNOS to Provide Retinal Image Analysis using its AI Technology to 20/20NOW

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, UAE, Saudi Arabia, Mexico, Costa Rica and others. The company's key revenue is derived from Canada.

Latest News

More News

Latest News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES